Source:http://linkedlifedata.com/resource/pubmed/id/19913615
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2010-2-22
|
pubmed:abstractText |
The biological roles of hyaluronan (HA) fragments in angiogenesis acceleration have been investigated recently. Studies have confirmed that oligosaccharides of HA (o-HA) are capable of stimulating neovascularization in vitro and promoting blood flow or angiogenesis in animal models. However, few laboratories have studied the function of o-HA as an exogenous treatment in injured tissue repair in vivo. It is thought that o-HA may lose its activities when used topically in vivo due to its small size, which may be absorbed quickly by the surrounding tissues. In this study, we prepared a special slow-releasing gel that contains a mixture of defined size of o-HA and studied the healing effects of o-HA by topical application to an acute wound model. We report that o-HA complex promotes the repair of tissue injury of a murine excisional dermal wound. The therapy by o-HA was compared with high molecular weight HA (HMW-HA) and the known angiogenesis stimulator, VEGF. At days 6 to 8 after treatment, significant differences were seen in wound closure rates between o-HA and control or HMW-HA groups, in which o-HA showed an increased wound recovery. Histological analysis revealed that increased neo-blood and lymph vessels were formed in wounded tissues treated by o-HA. In addition, treatments of wounds with o-HA resulted in more granulation production, collagen deposition, and fibroblast proliferation. Analysis of gene expression by real-time RT-PCR demonstrated a significant up-regulation of some cytokines or adhesion molecules in o-HA-treated wounds, which corresponds with the increased granulation tissue in these wounds. Our findings suggested that o-HA therapy may be useful in acute wound repair.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
1569-1802
|
pubmed:author | |
pubmed:copyrightInfo |
2009. Published by Elsevier B.V.
|
pubmed:issnType |
Electronic
|
pubmed:volume |
29
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
107-16
|
pubmed:meshHeading |
pubmed-meshheading:19913615-Animals,
pubmed-meshheading:19913615-Biological Markers,
pubmed-meshheading:19913615-Extracellular Matrix,
pubmed-meshheading:19913615-Humans,
pubmed-meshheading:19913615-Hyaluronic Acid,
pubmed-meshheading:19913615-Mice,
pubmed-meshheading:19913615-Mice, Inbred C57BL,
pubmed-meshheading:19913615-Neovascularization, Physiologic,
pubmed-meshheading:19913615-RNA, Messenger,
pubmed-meshheading:19913615-Skin,
pubmed-meshheading:19913615-Vascular Endothelial Growth Factor A,
pubmed-meshheading:19913615-Wound Healing
|
pubmed:year |
2010
|
pubmed:articleTitle |
Hyaluronan oligosaccharides promote excisional wound healing through enhanced angiogenesis.
|
pubmed:affiliation |
Department of Molecular Biology, Shanghai Sixth People's Hospital, Shanghai Jiaotong University School of Medicine, PR China. gaofengc@online.sh.cn
|
pubmed:publicationType |
Journal Article
|